Tafasitamab Biosimilar - Ultra Low Endotoxin
Product Specifications
Background
Uses the same sequence as the therapeutic antibody Tafasitamab
Product Name Alternative
B4, CVID3, Leu-12
Reactivity
Human
Target
CD19
Sequence
https://www.imgt.org/mAb-DB/
Applications
Functional Assays
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
5mg/mL
Endotoxin
<0.1EU/mg Determined by LAL gel clotting assay
Purity
≥95% monomer by analytical SEC, >95% by SDS Page
Buffer
ICH3002
Shipping Conditions
Blue ice
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Fragment
Human IgG1 (S239D/K274Q/Y296F/Y300F/L309V/I332E/A339T/V397M) -Kappa
Specificity
Detects human CD19
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Applications Notes
This biosimilar is for research use only (RUO) : it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
TMEM26 Peptide - C-terminal region (AAP71768)
FAM148A sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)